Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines (Q41729795)
Jump to navigation
Jump to search
scientific article published on 25 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines |
scientific article published on 25 July 2016 |
Statements
1 reference
Assessment of dual-probe Her-2 fluorescent in situ hybridization in breast cancer by the 2013 ASCO/CAP guidelines produces more equivocal results than that by the 2007 ASCO/CAP guidelines (English)
1 reference
Xiao-Long Qian
1 reference
Hannah Y Wen
1 reference
Yi-Ling Yang
1 reference
Feng Gu
1 reference
Xiao-Jing Guo
1 reference
Fang-Fang Liu
1 reference
Xin-Min Zhang
1 reference
Li Fu
1 reference
25 July 2016
1 reference
1 reference
31-39
1 reference
1 reference
1 reference
2 references
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference